STOCK TITAN

Summit Therapeutics (SMMT) Total Assets by Year

SMMT NASDAQ

Summit Therapeutics Inc. closed fiscal year 2025 with $751.2M in total assets, $92.3M in total liabilities and $658.9M in shareholder equity. Total assets rose 72.5% from the prior fiscal year. The table below carries 9 fiscal years, from 2018 to 2025, and the quarters Summit Therapeutics Inc. has filed alongside them.

FY2025 annual
Total Assets $751.2M
Total Liabilities $92.3M
Total Equity $658.9M
YoY +72.5%
5Y CAGR +48.9%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SMMT Balance Sheet by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY22FilingFY2110-KFY2010-KFY1910-KFY1910-KFY1810-K
Total Assets$751.2M+72.5%$435.6M+114.6%$202.9M-69.4%$664.2M+485.8%$113.4M+10.6%$102.5M+6.5%$96.2M$79.6M+1.7%$78.2M
Total Liabilities$92.3M+97.2%$46.8M-62.6%$125.3M-76.7%$537.5M+1686.4%$30.1M+30.6%$23.0M+32.6%$17.4M$47.4M-42.7%$82.7M
Total Equity$658.9M+69.5%$388.7M+400.4%$77.7M-38.7%$126.7M+52.1%$83.3M+4.8%$79.5M+0.7%$78.9M$32.2Mn/m-$3.6M

SMMT Balance Sheet by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'25FilingQ4'2410-KQ3'2410-QQ2'24FilingQ1'24FilingQ4'2310-K
Total Assets$692.9M+164.7%$752.2M+132.1%$647.9M+68.8%$751.2M+72.5%$261.7M-48.0%$324.0M-5.2%$383.8M+117.1%$435.6M+114.6%$502.9M+130.2%$341.9M+44.0%$176.8M-30.6%$202.9M-69.4%
Total Liabilities$128.2M+84.5%$122.2M+89.2%$101.9M+158.1%$92.3M+97.2%$69.5M+7.0%$64.6M-56.0%$39.5M-70.2%$46.8M-62.6%$64.9M-45.5%$146.8M+24.6%$132.6M+9.2%$125.3M-76.7%
Total Equity$564.7M+193.7%$630.0M+142.8%$545.9M+58.5%$658.9M+69.5%$192.3M-56.1%$259.4M+33.0%$344.3M+678.9%$388.7M+400.4%$437.9M+340.7%$195.1M+63.1%$44.2M-66.9%$77.7M-38.7%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Summit Therapeutics Inc. financials

Frequently Asked Questions

Summit Therapeutics Inc. closed fiscal year 2025 with $751.2M in total assets, $92.3M in total liabilities and $658.9M in shareholder equity.

Summit Therapeutics Inc. (SMMT) total assets rose by 72.5% year over year, from $435.6M to $751.2M in fiscal year 2025.

Across the 9 fiscal years this page covers, Summit Therapeutics Inc. (SMMT) total assets went from $78.2M in fiscal year 2018 to $751.2M in fiscal year 2025.

Summit Therapeutics Inc. (SMMT) reported $692.9M in total assets in Q3 2026. This represents an increase of 164.7% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Summit Therapeutics Inc. (SMMT) reported on that line in every period on record.